Effects of Pregnancy-Specific Anxiety on Placental Inflammatory and Oxidative Stress Response and Birth Outcomes
Launched by HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE · Aug 3, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how anxiety during pregnancy affects the placenta, which is the organ that provides nutrients and oxygen to the baby. Researchers want to understand if higher levels of anxiety in expectant mothers can lead to changes in the placenta that might impact pregnancy outcomes, such as the health of the baby at birth. They will be examining different types of cells in the placenta that can show if there is inflammation or stress, which could affect the pregnancy.
To participate in this study, women must be at least 18 years old, currently pregnant, and receiving prenatal care at BAMC (Brooke Army Medical Center). Participants should also be able to speak English and be active-duty members of the military or their beneficiaries. If you join the study, you can expect to provide information about your anxiety levels and undergo some tests related to your pregnancy. This research is important as it may help improve understanding of how stress during pregnancy could influence both maternal and infant health.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • All Active Duty and DoD beneficiary gravid women,
- • 18 years of age or older,
- • Receiving prenatal care at BAMC,
- • English speaking
- Exclusion Criteria:
- • Military dependent daughters
- • VA beneficiaries
About Henry M. Jackson Foundation For The Advancement Of Military Medicine
The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) is a non-profit organization dedicated to advancing military medicine through research, education, and innovation. Established in 1983, HJF collaborates with the U.S. military, academic institutions, and industry partners to facilitate the development and implementation of medical solutions that enhance the health and well-being of service members and their families. Through its support of clinical trials and scientific research initiatives, HJF plays a pivotal role in translating cutting-edge medical discoveries into effective treatments, ultimately contributing to the improvement of healthcare delivery within military and civilian populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Antonio, Texas, United States
Patients applied
Trial Officials
Monica Lutgendorf, MD
Principal Investigator
Uniformed Services University of the Health Sciences
Robert O Brady, MD
Principal Investigator
59 Medical Wing
Tony T Yuan, PhD
Principal Investigator
Uniformed Services University of the Health Sciences
Karen L Weis, PhD
Principal Investigator
University of Kansas Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials